Cost-Effectiveness of Dual Bronchodilator Indacaterol/Glycopyrronium for COPD Treatment in China

BACKGROUND: Indacaterol/glycopyrronium (IND/GLY) is a once-daily dual bronchodilator for long-term treatment of patients with chronic obstructive pulmonary disease (COPD). The efficacy and safety of IND/GLY have been proved before, but the cost-effectiveness is unknown in China. PURPOSE: This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Shiyi, Hu, Hao, Zhao, Kun, Yang, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914055/
https://www.ncbi.nlm.nih.gov/pubmed/33654393
http://dx.doi.org/10.2147/COPD.S276476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914055/
https://www.ncbi.nlm.nih.gov/pubmed/33654393
http://dx.doi.org/10.2147/COPD.S276476

Ejemplares similares